查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540958

2024-2032 年内视镜逆行性胰胆管摄影市场报告（依产品、手术、最终使用者及地区）

Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球内视镜逆行性胰胆管摄影市场规模达16亿美元。

内视镜逆行性胰胆管摄影 (ERCP) 是一种诊断和治疗肝臟、胆囊、胆管和胰臟异常的影像技术。它结合了 X 光和一根长的、灵活的、轻质的内视镜管，穿过食道、口腔和胃。它有助于检测胆管中的阻塞、结石、感染和肿瘤以及胰管的液体渗漏。除此之外，它是一种比开放性手术侵入性更小的手术，并且提供有关胰胆系统的更详细和准确的资讯。因此，全球对用于治疗吞嚥困难、腹泻、体重减轻、胃灼热和便血的内治疗设备的需求不断增加。

内视镜逆行性胰胆管摄影市场趋势：

全球人口不断增长，各种慢性胃肠道(GI) 和持续性胆道疾病（包括巴雷特病、胆道病、肝病、克隆氏症、发炎性肠道疾病、消化性溃疡疾病以及胃食道逆流病(GERD)）的盛行率不断上升，代表了其中之一。此外，良性胰臟和肝臟肿瘤的发生率不断增加，尤其是在老年族群中，以及全球癌症发生率的不断上升，正在推动市场的发展。与此一致的是，医院和诊断中心的扩张增加了对影像技术的需求，推动了市场的成长。此外，各国政府和医疗机构对先进内视镜设备和改进内视镜研究的投资不断增加，正在加强市场成长。除此之外，消费者对微创手术的偏好转变，以实现快速康復和最小化疼痛，以及对括约肌切开刀等 ERCP 设备的认识不断提高，这些都提供了良好的市场前景。此外，医疗基础设施的不断改善和医疗旅游业的大幅增长预计将推动市场成长。

本报告回答的关键问题

  • 全球内视镜逆行性胰胆管摄影市场有多大？ 2024-2032年全球内视镜逆行性胰胆管摄影市场的预期成长率为何？
  • 推动全球内视镜逆行性胰胆管摄影市场的关键因素是什么？
  • COVID-19对全球内视镜逆行性胰胆管摄影市场有何影响？
  • 基于该产品的全球内视镜逆行性胰胆管摄影市场的细分如何？
  • 基于手术的全球内视镜逆行性胰胆管摄影市场的细分如何？
  • 基于最终用户的全球内视镜逆行性胰胆管摄影市场的细分如何？
  • 全球内视镜逆行性胰胆管摄影市场的关键区域有哪些？
  • 全球内视镜逆行性胰胆管摄影市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球内视镜逆行性胰胆管摄影市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 内视镜
    • 市场趋势
    • 市场预测
  • 内视镜治疗设备
    • 市场趋势
    • 关键环节
      • 括约肌切开器
      • 碎石机
      • 支架
      • 其他的
    • 市场预测
  • 可视化系统
    • 市场趋势
    • 市场预测
  • 能源设备
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按程序

  • 胆管括约肌切开术
    • 市场趋势
    • 市场预测
  • 胆道支架置入术
    • 市场趋势
    • 市场预测
  • 胆道扩张
    • 市场趋势
    • 市场预测
  • 胰臟括约肌切开术
    • 市场趋势
    • 市场预测
  • 胰管支架置入术
    • 市场趋势
    • 市场预测
  • 胰管扩张
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 门诊手术中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boston Scientific Corporation
    • CONMED Corporation
    • Cook Group Incorporated
    • Fujifilm Holdings Corporation
    • Hobbs Medical Inc.
    • Johnson & Johnson
    • Medi-Globe GmbH
    • Medtronic plc
    • Olympus Corporation
    • Shaili Endoscopy
    • Steris Corporation
    • Telemed Systems Inc.
Product Code: SR112024A6442

The global endoscopic retrograde cholangiopancreatography market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.88% during 2024-2032.

Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.

Endoscopic Retrograde Cholangiopancreatography Market Trends:

The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global endoscopic retrograde cholangiopancreatography market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, procedure and end user.

Breakup by Product:

Endoscope

Endotherapy Devices

Sphincterotomes

Lithotripter

Stents

Others

Visualization Systems

Energy Devices

Others

Breakup by Procedure:

Biliary Sphincterotomy

Biliary Stenting

Biliary Dilatation

Pancreatic Sphincterotomy

Pancreatic Duct Stenting

Pancreatic Duct Dilatation

Breakup by End User:

Hospitals and Clinics

Ambulatory Surgery Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.

Key Questions Answered in This Report

  • 1. How big is the global endoscopic retrograde cholangiopancreatography market?
  • 2. What is the expected growth rate of the global endoscopic retrograde cholangiopancreatography market during 2024-2032?
  • 3. What are the key factors driving the global endoscopic retrograde cholangiopancreatography market?
  • 4. What has been the impact of COVID-19 on the global endoscopic retrograde cholangiopancreatography market?
  • 5. What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the product?
  • 6. What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the procedure?
  • 7. What is the breakup of the global endoscopic retrograde cholangiopancreatography market based on the end user?
  • 8. What are the key regions in the global endoscopic retrograde cholangiopancreatography market?
  • 9. Who are the key players/companies in the global endoscopic retrograde cholangiopancreatography market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endoscopic Retrograde Cholangiopancreatography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Endoscope
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Endotherapy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Sphincterotomes
      • 6.2.2.2 Lithotripter
      • 6.2.2.3 Stents
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Visualization Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Energy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Biliary Sphincterotomy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biliary Stenting
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biliary Dilatation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Sphincterotomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Pancreatic Duct Stenting
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pancreatic Duct Dilatation
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boston Scientific Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 CONMED Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fujifilm Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hobbs Medical Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medi-Globe GmbH
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Olympus Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Shaili Endoscopy
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Steris Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Telemed Systems Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Major Drivers and Challenges
  • Figure 2: Global: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Procedure (in %), 2023
  • Figure 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Endoscopic Retrograde Cholangiopancreatography Industry: SWOT Analysis
  • Figure 86: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Value Chain Analysis
  • Figure 87: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
  • Table 4: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Competitive Structure
  • Table 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Key Players